Skip to main content

Question for Department of Health and Social Care

UIN 16975, tabled on 13 June 2022

To ask the Secretary of State for Health and Social Care, what his planned timetable is for making a decision on the use of Evusheld following conclusion of UKHSA testing.

This answer is the replacement for a previous holding answer.

Answered on

21 June 2022

AstraZeneca commissioned the UK Health Strategic Authority to conduct studies into the effectiveness of Evusheld against the Omicron variants. Initial data has been shared with AstraZeneca. The Department is also assessing Evusheld through requesting advice from clinicians on the most appropriate option for the National Health Service in line with available data, the public health situation and other treatments available. While we expect to receive clinical advice shortly we are unable to confirm a specific timetable.

Named day
Named day questions only occur in the House of Commons. The MP tabling the question specifies the date on which they should receive an answer. MPs may not table more than five named day questions on a single day.